HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach

<div>(a) Concordant HER2 status in primary GC (original magnification, ×320; Mayer’s Haemalum nuclear counterstain) and (b) corresponding metastatic lymph node (original magnification, ×160; Mayer’s Haemalum nuclear counterstain).</div>

Disease Markers

fig3

Figure 3

Figure 3: HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach 